CEN/TC 206
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 60722 | LVS EN ISO 10993-9:2021 | Biological evaluation of medical devices - Part 9: Framework for identification and quantification of potential degradation products (ISO 10993-9:2019) | Standarts spēkā |
| 60721 | LVS EN ISO 10993-1:2021 | Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO 10993-1:2018, including corrected version 2018-11) | Standarts spēkā |
| 60721 | EN ISO 10993-1:2020 | Biological evaluation of medical devices - Part 1: Evaluation and testing within a risk management process (ISO/DIS 10993-1:2017) | Atcelts |
| 60214 | EN ISO 22442-2:2015 | Medical devices utilizing animal tissues and their derivatives - Part 2: Controls on sourcing, collection and handling (ISO/FDIS 22442-2:2015) | Atcelts |
| 60213 | EN ISO 22442-1:2015 | Medical devices utilizing animal tissues and their derivatives - Part 1: Application of risk management (ISO/FDIS 22442-1:2015) | Atcelts |
| 60133 | LVS EN ISO 10993-11:2018 | Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO 10993-11:2017) | Standarts spēkā |
| 60133 | EN ISO 10993-11:2018 | Biological evaluation of medical devices - Part 11: Tests for systemic toxicity (ISO/DIS 10993-11:2015) | Standarts spēkā |
| 40815 | EN ISO 10993-4:2017 | Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood (ISO/DIS 10993-4:2015) | Atcelts |
| 40815 | LVS EN ISO 10993-4:2017 | Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood (ISO 10993-4:2017) | Atcelts |
| 40814 | prEN ISO 10993-5 rev | Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009) | Izstrādē |
Displaying 61-70 of 194 results.